Treatment of Necrobiosis Lipoidica with 595 nm Pulsed Dye Laser - A Case Report

Michel, Jean‐Loïc; Richard, Odile

doi:10.2174/1874372200802010022

Cited by 7 publications

(9 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the 1980s–1990s, there were reports of argon, Nd:YAG and potassium titanyl phosphate laser, but recent reports are primarily about treatment using dye laser. Morelli et al.…”

Section: Resultsmentioning

confidence: 99%

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Mimura

Akita

Fujino

et al. 2020

The Journal of Dermatology

View full text Add to dashboard Cite

The objective was to prepare guidelines to perform the current optimum treatment by organizing effective and efficient treatments of hemangiomas and vascular malformations, confirming the safety and systematizing treatment, employing evidence-based medicine techniques and aimed at improvement of the outcomes. Clinical questions (CQ) were decided based on the important clinical issues. For document retrieval, key words for published work searches were set for each CQ, and work published from 1980 to the end of September 2014 was searched in PubMed, Cochrane Library and Japana Centra Revuo Medicina databases. The strengths of evidence and recommendations acquired by systematic reviews were determined following the Medical Information Network Distribution System technique. A total of 33 CQ were used to compile recommendations and the subjects included efficacy of resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy and other conservative treatment, differences in appropriate treatment due to the location of lesions and among symptoms, appropriate timing of treatment and tests, and pathological diagnosis deciding the diagnosis. Thus, the Japanese Clinical Practice Guidelines for Vascular Anomalies 2017 have been prepared as the evidence-based guidelines for the management of vascular anomalies.

show abstract

“…In the 1980s–1990s, there were reports of argon, Nd:YAG and potassium titanyl phosphate laser, but recent reports are primarily about treatment using dye laser. Morelli et al.…”

Section: Resultsmentioning

confidence: 99%

Japanese Clinical Practice Guidelines for Vascular Anomalies 2017

Mimura

Akita

Fujino

et al. 2020

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…One study showed no difference between complete and nearly complete clearance with early laser treatment compared to observation alone at 1 year of age. 72 Other studies have demonstrated good results with either the 585 nm PDL or 595 nm PDL on superficial IH, but not deep IH. 73,74 Severe ulceration and scarring have been reported, particularly when treating segmental hemangiomas during the proliferative phase.…”

Section: Treatmentmentioning

confidence: 96%

Infantile hemangiomas: from pathogenesis to clinical features

Rosenblatt¹,

Mathes²,

Rosbe

2012

RRN

View full text Add to dashboard Cite

Infantile hemangiomas (IH) are benign vascular tumors consisting of a collection of immature cells, including progenitor stem cells and disorganized blood vessels. They are the most common benign tumors in childhood. Recently, there have been significant, exciting advancements in the understanding of the pathogenesis and treatment of infantile hemangiomas, which are discussed in this review. The decision to initiate treatment for IH is based on many factors, including size and location, functional compromise, psychosocial implications, and risks and benefits of the proposed therapy. For most families of children with hemangiomas, education about the natural history of IH and reassurance are often the only "treatment" required. A minority of patients with large, complex lesions or lesions that cause functional compromise require early intervention. These patients and families benefit from a multidisciplinary approach to care in vascular birthmark centers. Ongoing multi-institutional clinical trials will provide further important data on the efficacy and safety of hemangioma treatments.

show abstract

“…The choice of laser depends on location, depth and size of the lesion. Flash lamp pumped pulsed dye laser with a wavelength of 585 or 595mm is the only laser that photo coagulates the target vessels leaving the overlying skin intact thereby making it useful for superficial Hemangiomas or those at involution stage, however it is of little use in deep seated Hemangiomas because of limited penetration depth 29 . Neodymium Yttrium aluminum garnet laser (Nd:YAG) having wavelength of 1064nm and penetration depth of 5mm is the choice for larger or 2cm deep seated Hemangiomas.…”

Section: Vimanagementmentioning

confidence: 99%